Completed PHASE4 INTERVENTIONAL 2-arm NCT01535716

Effects of a Goal-directed Hemodynamic Therapy Driven by ECOM on Morbidity and Mortality After Cardiac Surgery? (ECOMIII)

Does Goal-directed Hemodynamic Therapy Driven by Endotracheal Cardiac Output Monitoring System During Surgical Intervention Reduce Hospital Stay and Major Adverse Cardiac Events Following Cardiac Surgery?

Sponsor: CONMED Corporation

Conditions Coronary Surgery With Cardiopulmonary Bypass

Interventions hemodynamic optimization strategy driven by the ECOM standard management strategy

Updated 6 times since 2017 Last updated: Apr 16, 2013 Started: Feb 29, 2012 Primary completion: Feb 28, 2013 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Surgery With Cardiopulmonary Bypass, this trial is completed. The trial is conducted by CONMED Corporation and has accumulated 6 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2023 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Sep 2023 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CONMED Corporation
University Hospital, Caen

Data source: University Hospital, Caen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Caen, France